Plain-English translation of NCT04240834 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After a heart attack treated with a stent, patients typically take two blood-thinning medications to prevent future problems. This study is testing whether using combined with a lower dose of works just as well—or even better—than the standard higher dose of , while potentially causing fewer bleeding side effects.
The standard treatment after a heart attack involves two blood-thinning medications, but this can increase bleeding risk. Researchers want to know if using a lower dose might provide the same heart protection while reducing dangerous bleeding complications.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either a lower dose or standard dose of —plus another medication called —for 12 months. You'll take these pills twice daily and visit the hospital for regular check-ups to monitor how well the treatment works and whether you experience any bleeding or other side effects. The study aims to track whether you have any heart-related problems or bleeding complications over that year.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
China